Wall Street Experts
ver. ZuMIgo(08/25)
Hunan Jiudian Pharmaceutical Co., Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 2 920
EBIT TTM (mln): 540
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
Rok finansowy |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
241 |
266 |
290 |
376 |
535 |
801 |
924 |
978 |
1,628 |
2,326 |
2,693 |
2,931 |
Przychód Δ r/r |
0.0% |
10.4% |
9.0% |
29.6% |
42.0% |
49.9% |
15.3% |
5.9% |
66.4% |
42.9% |
15.7% |
8.8% |
Marża brutto |
55.0% |
52.0% |
51.7% |
51.4% |
51.9% |
59.6% |
67.5% |
74.8% |
78.5% |
77.8% |
76.9% |
73.2% |
EBIT (mln) |
24 |
40 |
45 |
61 |
75 |
80 |
63 |
92 |
226 |
291 |
394 |
575 |
EBIT Δ r/r |
0.0% |
67.3% |
12.6% |
33.7% |
23.1% |
7.2% |
-21.6% |
45.8% |
146.2% |
29.0% |
35.4% |
45.8% |
EBIT (%) |
10.0% |
15.2% |
15.7% |
16.2% |
14.0% |
10.0% |
6.8% |
9.4% |
13.9% |
12.5% |
14.6% |
19.6% |
Koszty finansowe (mln) |
2 |
1 |
1 |
1 |
1 |
1 |
5 |
5 |
16 |
18 |
11 |
19 |
EBITDA (mln) |
35 |
57 |
62 |
77 |
96 |
105 |
106 |
155 |
317 |
387 |
486 |
686 |
EBITDA(%) |
14.5% |
21.4% |
21.5% |
20.4% |
18.0% |
13.1% |
11.4% |
15.8% |
19.5% |
16.6% |
18.0% |
23.4% |
Podatek (mln) |
4 |
6 |
5 |
8 |
8 |
7 |
4 |
9 |
22 |
21 |
34 |
60 |
Zysk Netto (mln) |
25 |
38 |
45 |
55 |
69 |
72 |
55 |
82 |
204 |
270 |
368 |
512 |
Zysk netto Δ r/r |
0.0% |
49.6% |
18.1% |
22.1% |
25.8% |
5.0% |
-23.5% |
49.4% |
148.3% |
32.0% |
36.5% |
39.1% |
Zysk netto (%) |
10.5% |
14.2% |
15.4% |
14.5% |
12.8% |
9.0% |
6.0% |
8.4% |
12.5% |
11.6% |
13.7% |
17.5% |
EPS |
0.22 |
0.29 |
0.2 |
0.23 |
0.26 |
0.22 |
0.17 |
0.25 |
0.62 |
1.97 |
0.77 |
1.05 |
EPS (rozwodnione) |
0.22 |
0.29 |
0.2 |
0.23 |
0.26 |
0.22 |
0.17 |
0.25 |
0.62 |
1.97 |
0.76 |
1.04 |
Ilośc akcji (mln) |
116 |
132 |
227 |
242 |
267 |
325 |
329 |
329 |
329 |
137 |
482 |
488 |
Ważona ilośc akcji (mln) |
116 |
132 |
227 |
242 |
267 |
325 |
329 |
329 |
329 |
137 |
504 |
493 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |